Global Cardiac Biomarkers Market Trends, Business Strategies, Regional Outlook, Challenges and Analysis Through, 2030

According to the latest market research study published by P&S Intelligence, the global cardiac biomarkers market is poised to grow from USD 20.8 billion in 2024 to an impressive USD 44.6 billion by 2030, advancing at a CAGR of 13.4% during 2025-2030. This robust growth is largely fueled by the escalating prevalence of acute coronary syndromes (ACS), driving demand for accurate, timely, and non-invasive diagnostic tools.

Technological advancements such as high-sensitivity troponin assays have revolutionized early detection, reducing diagnostic uncertainty and enabling faster clinical decision-making. Point-of-care (PoC) testing kits have gained popularity, especially in emergency settings, for their ability to deliver rapid results. Additionally, increased R&D investments from both governmental and private sectors are fostering innovation in diagnostic biomarkers.

The aging population, which is particularly vulnerable to cardiovascular diseases (CVDs), continues to bolster demand for cardiac biomarkers. Moreover, rising awareness among healthcare professionals and patients about the importance of early diagnosis is further accelerating market adoption.

Browse the full report with a detailed analysis on: https://www.psmarketresearch.com/market-analysis/cardiac-biomarker-market

Key Insights

• Troponins hold the largest market share, generating over 30% of the revenue in 2024. Their high specificity in detecting ACS makes them a cornerstone in cardiac diagnostics.

• B-type natriuretic peptides (BNPs) are the fastest-growing biomarker category due to their effectiveness in diagnosing and managing congestive heart failure (CHF). The rise in CHF cases, including 6.2 million people affected in the U.S., is driving demand for BNP and NT-proBNP tests.

• Myocardial infarction represents the leading application segment, owing to its high global incidence and reliance on rapid biomarker testing for diagnosis and treatment.

• Laboratory testing remains the primary method for cardiac biomarker analysis; however, PoC testing is gaining momentum due to its speed and suitability in acute care scenarios.

• North America leads the global market, driven by advanced healthcare infrastructure, widespread awareness, and ongoing technological innovations in diagnostic testing.

• Asia-Pacific is the fastest-growing region, propelled by increasing investments in healthcare infrastructure, a large patient base, and growing awareness about cardiovascular health.

Download free report sample at: https://www.psmarketresearch.com/market-analysis/cardiac-biomarker-market/report-sample

• Artificial intelligence (AI) and machine learning (ML) are emerging as transformative technologies in this market. AI-based diagnostic tools enhance the detection and interpretation of biomarker data, supporting personalized treatment strategies.

• AI integration into PoC devices and wearable health monitors is enabling real-time patient monitoring and reducing hospital readmissions, thereby improving long-term outcomes.

• The use of biomarkers in personalized medicine is expanding, with AI-driven analytics allowing clinicians to tailor interventions based on individual cardiac profiles.

• Market players are focusing on collaborations with healthcare providers to increase accessibility and distribution of advanced diagnostic kits, further expanding market reach.

• Despite strong growth, the market faces challenges related to the limited specificity of some biomarkers. Elevated levels can sometimes result from non-cardiac conditions, potentially leading to misdiagnosis and delayed treatment.

• Roche Diagnostics India recently launched a PoC NT-proBNP test in April 2024, reflecting the industry's focus on improving CHF diagnosis through faster, more accessible testing.

About P&S Intelligence

P&S Intelligence offers custom and syndicated market research and consulting services to clients across the globe. Our team of young and dynamic researchers, guided by mentors with years of experience, create data-rich reports tailored to the needs of MNCs as well as startups and SMEs. We remain in a perennial quest to offer exhaustive insights into every aspect of the market, allowing businesses of all sizes to seize even the smallest of opportunities and tackle even the biggest of challenges.

Contact:
Chandra Mohan
AVP - Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: https://psintelligence.blogspot.com

This release was published on openPR.